[Comparative study of BRL28500 (clavulanic acid-ticarcillin) and ticarcillin in the treatment of respiratory tract infections]. 1987

F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002969 Clavulanic Acids Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. Acids, Clavulanic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
October 1986, The Journal of antibiotics,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
January 1987, Acta Europaea fertilitatis,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
November 1985, The American journal of medicine,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
May 1991, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
May 1986, The Journal of antimicrobial chemotherapy,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
November 1985, The American journal of medicine,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
April 1987, The Japanese journal of antibiotics,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
January 1985, Drugs under experimental and clinical research,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
January 1992, Diagnostic microbiology and infectious disease,
F Miki, and Y Ikuno, and E Inoue, and A Murata, and S Tanizawa, and K Sakamoto, and A Tahara, and A Saito, and M Tomizawa, and Y Hiraga
November 1989, Clinical pediatrics,
Copied contents to your clipboard!